Company
United StatesStaska Pharmaceuticals, Inc. – FDA Inspections
Inspection records and compliance data for Staska Pharmaceuticals, Inc.. 2 FDA inspections on record (1 OAI), 2 Form 483s, 1 warning letter, last inspected February 20, 2026.
Company Profile
This profile covers Staska Pharmaceuticals, Inc. based in United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 1
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 1
First inspected September 18, 2024. Last inspected February 20, 2026.
Most cited issue areas
- Environmental Monitoring System1 inspection
- Investigations of discrepancies, failures1 inspection
- Scientifically sound laboratory controls1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 20, 2026 | Not classified | Human Drugs · Drug Quality Assurance | 1304594 |
| September 18, 2024 | OAI | Human Drugs · Drug Quality Assurance | 1251377 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Han C. Phan, M.D.
Medoz Pharmacy of Polk Inc
ASP Cares
BBS Pharmacy, Inc. dba B&B Pharmacy
Loop Plaza Pharmacy Company DBA Loop Compounding Pharmacy
Richard W. Foltin, Ph.D.
San Diego Compounding Pharmacy
Maple Rose Enterprises, Inc, dba Pencol Pharmacy
KRS Global Biotechnology, Inc
North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
Company Information
Name
Staska Pharmaceuticals, Inc.
FEI Number
3017473850
Address
United States
Country
United States
ID: 1f0a154e-2760-411a-9de6-78da1634f8fc